Degradation of Matrix Proteins in Liver Fibrosis
- 1 October 1994
- journal article
- review article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 190 (9-10), 825-833
- https://doi.org/10.1016/s0344-0338(11)80985-4
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.Journal of Clinical Investigation, 1992
- “Cuts both ways”: Collagenases, lipocyte activation and polyunsaturated lecithinHepatology, 1992
- Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liverVirchows Archiv B Cell Pathology Including Molecular Pathology, 1991
- Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin GFEBS Letters, 1989
- Cultured Ito cells of rat liver express the alpha2-macroglobulin geneEuropean Journal of Biochemistry, 1987
- Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagenBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985
- Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosisLife Sciences, 1982
- Collagenase activity in experimental hepatic fibrosisNature, 1974
- The presence of collagenase in Kupffer cells of the rat liverBiochemical and Biophysical Research Communications, 1973